Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#3931 Construction and comparison of non-functional pancreatic neuroendocrine tumor models
Introduction: Pancreatic neuroendocrine tumors (PNET) which account for more than 80% of pancreatic neuroendocrine neoplasm (pNEN) can be divided into functional and non-functional. The non-functional pancreatic neuroendocrine tumor (NF-pNET) without hormone-related clinical symptoms is frequently found by chance during physical examination or in large primaries and late stages of disease.
Conference:
Presenting Author: Wang Y
Authors: Wang Y, Ye Z, Lou X, Xu J, Zhou C,
Keywords: pancreatic neuroendocrine tumor, preclinical model, cell line, patient-derived organoid, patient-derived xenograft,
Introduction: Insulinoma is a functioning pancreatic neuroendocrine tumor (pNET) that produces insulin and causes clinical symptoms of severe hypoglycemia. The arterial calcium stimulation with hepatic venous sampling (ASVS) can localize the insulin-producing tumor and help to avoid the excessive volume of surgery in case of multiple pancreatic neuroendocrine tumors.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Kaldarov A
Authors: Kaldarov A, Panteleev V, Varava A, Raevskaya M, Davidenko P,
Keywords: insulinoma, neuroendocrine tumor, neuroendocrine neoplasm, pancreas, arterial calcium stimulation with hepatic venous sampling, ASVS, parenchyma-sparing surgery,
#2930 Treatment of the Pinealoma: Experience from a Rare Case
Introduction: Pinealoma is an extremely rare type of neuroendocrine tumor without evidence-based systemic therapy.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Zhang Y, Liu M, Chen L, Guo Y, Chen M,
Keywords: pinealoma, octreotide, interferon.,
#2290 PRRT in Hindgut and Cancer of Unknown Primary NEN
Introduction: There are limited data regarding PRRT in hindgut and CUP (cancer of unknown primary).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Ćwikla J
Authors: Kolasińska-Ćwikła A, Lewczuk-Myślińska A, Cichocki A, Roszkowska-Purska K, Dobkowski P,
Introduction: From March 2016, patients with M+ NET are treated with PRRT at the Netherlands Cancer Institute.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Huizing D, Versleijen M, Geluk - Jonker M, Hendrikx J, De Wit - Van Der Veen L,
Keywords: PRRT, adverse events, clinical symptoms,